Clinical Trials Browser

Transplant-Related Hematologic Malignancy × sargramostim × 90 days × Clear all

NCT04237623 2026-04-16

GM-CSF With Post-Transplant Cyclophosphamide

Phase 2 Recruiting

Transplant-Related Hematologic Malignancy